GLAUKOS Corp Sales Revenue, Goods, Net (Deprecated 2018-01-31)
GLAUKOS Corp (GKOS) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $41.65 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-02-28
- GLAUKOS Corp sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $41.65M, a 25.56% increase year-over-year.
- GLAUKOS Corp sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $40.41M, a 36.63% increase year-over-year.
- GLAUKOS Corp sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $41.28M, a 44.58% increase year-over-year.
- GLAUKOS Corp sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $35.91M, a 55.50% increase year-over-year.
- GLAUKOS Corp sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $159.25M, a 39.21% increase from fiscal 2016.
- GLAUKOS Corp sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $114.40M, a 59.55% increase from fiscal 2015.
- GLAUKOS Corp sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $71.70M, a 57.28% increase from fiscal 2014.
- GLAUKOS Corp sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $45.59M, a 117.64% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $41.65M 10-K · filed 2018-02-28 | $82.06M derived: sum of 2 quarters · filed 2018-02-28 | $123.35M derived: sum of 3 quarters · filed 2018-02-28 | $159.25M 10-K · filed 2018-02-28 |
| 2017-09-30 | $40.41M 10-K · filed 2018-02-28 | $81.70M derived: sum of 2 quarters · filed 2018-02-28 | $117.60M 10-Q · filed 2017-11-08 | $150.78M derived: sum of 4 quarters · filed 2018-02-28 |
| 2017-06-30 | $41.28M 10-K · filed 2018-02-28 | $77.19M 10-Q · filed 2017-08-07 | $110.36M derived: sum of 3 quarters · filed 2018-02-28 | $139.94M derived: sum of 4 quarters · filed 2018-02-28 |
| 2017-03-31 | $35.91M 10-K · filed 2018-02-28 | $69.08M derived: sum of 2 quarters · filed 2018-02-28 | $98.66M derived: sum of 3 quarters · filed 2018-02-28 | $127.21M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-12-31 | $33.17M 10-K · filed 2018-02-28 | $62.75M derived: sum of 2 quarters · filed 2018-02-28 | $91.31M derived: sum of 3 quarters · filed 2018-02-28 | $114.40M 10-K · filed 2018-02-28 |
| 2016-09-30 | $29.58M 10-K · filed 2018-02-28 | $58.13M derived: sum of 2 quarters · filed 2018-02-28 | $81.22M 10-Q · filed 2017-11-08 | $101.50M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $28.56M 10-K · filed 2018-02-28 | $51.65M 10-Q · filed 2017-08-07 | $71.92M derived: sum of 3 quarters · filed 2018-02-28 | $90.93M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $23.09M 10-K · filed 2018-02-28 | $43.37M derived: sum of 2 quarters · filed 2018-02-28 | $62.37M derived: sum of 3 quarters · filed 2018-02-28 | $80.13M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $20.28M 10-K · filed 2017-03-15 | $39.28M derived: sum of 2 quarters · filed 2017-03-15 | $57.03M derived: sum of 3 quarters · filed 2017-03-15 | $71.70M 10-K · filed 2018-02-28 |
| 2015-09-30 | $19.00M 10-K · filed 2017-03-15 | $36.76M derived: sum of 2 quarters · filed 2017-03-15 | $51.42M 10-Q · filed 2016-11-14 | $65.54M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $17.75M 10-K · filed 2017-03-15 | $32.42M 10-Q · filed 2016-08-04 | $46.53M derived: sum of 3 quarters · filed 2017-03-15 | $58.66M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $14.67M 10-K · filed 2017-03-15 | $28.78M derived: sum of 2 quarters · filed 2017-03-15 | $40.91M derived: sum of 3 quarters · filed 2017-03-15 | $52.00M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $14.11M 10-K · filed 2016-03-15 | $26.24M derived: sum of 2 quarters · filed 2016-03-15 | $37.34M derived: sum of 3 quarters · filed 2016-03-15 | $45.59M 10-K · filed 2017-03-15 |
| 2014-09-30 | $12.13M 10-K · filed 2016-03-15 | $23.23M derived: sum of 2 quarters · filed 2016-03-15 | $31.47M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $11.10M 10-K · filed 2016-03-15 | $19.35M 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $8.25M 10-K · filed 2016-03-15 | |||
| 2013-12-31 | $20.95M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |